Skip to main content
Back to all tickers

Picard Medical, Inc. (PMI) stock forecast & analysis

1 analysis. Latest: .

Create a new scan for free

New accounts start with 200 free tokens.

Market Scanner’s AI analysis of Picard Medical, Inc. (PMI), updated August 2026: Picard Medical's recent analyses covered a sharp 7-day price surge against a backdrop of negative longer-term trends and operational losses.

Summary

Picard Medical's recent analyses covered a sharp 7-day price surge against a backdrop of negative longer-term trends and operational losses.

Recent analyses for Picard Medical, Inc. (PMI) examined a significant short-term price increase alongside a longer-term downtrend indicated by SMAs. The company reported strong year-over-year revenue growth but continued to post negative gross profit and net income. News highlights included a contract manufacturing collaboration with Altria and broader economic indicators influencing market sentiment.

PMI news & sentiment

News reports presented a mixed picture, highlighting a contract manufacturing collaboration and broader economic indicators influencing market sentiment. A separate headline indicated that strong Purchasing Managers' Index readings complicated the Federal Reserve's path, causing a slight dip in futures.

PMI technical picture

The 7-day price change showed strong upward momentum, though the 30-day and 91-day changes indicated a slowing trend and a longer-term decline, respectively. The price traded below its 50-day and 200-day SMAs, suggesting a negative medium- and long-term trend, while the 10-day EMA showed some short-term positive momentum. RSI readings were neutral, but MFI indicated extremely strong buying pressure.

Fundamentals

Picard Medical, Inc. (PMI) reported strong year-over-year revenue growth but has experienced negative gross profit and net income across recent periods. The company has reduced its total debt significantly, though it maintains a low cash balance and negative shareholder equity. Operating cash flow has also been negative over the past four reported annual periods.

Factors discussed — upside

  • Strong 7-day price change of +45.7%
  • Positive short-term momentum indicated by 10-day EMA
  • Extremely strong buying pressure indicated by MFI
  • Year-over-year revenue growth of 39.1%
  • Significant decrease in total debt

Factors discussed — risks

  • Slower momentum over the last 30 days compared to the last week
  • Significant 91-day price decline of -32.1%
  • Price below 50-day and 200-day SMAs
  • Negative gross profit in recent periods
  • Consistently negative net income and operating cash flow
  • Technical price trends
  • Financial performance
  • Balance sheet health
  • Contract manufacturing collaboration

Summary updated .

Analyses

Recent PMI.US analyses are locked — sign in to read them or generate a fresh one.

CaseDescriptionDate

Frequently asked questions

What is the bull case for Picard Medical, Inc.?
Recent analyses discussed a strong 7-day price change and positive short-term momentum, supported by extremely strong buying pressure indicated by the MFI. The company also reported year-over-year revenue growth of 39.1% and a significant decrease in total debt.
What are the risks for Picard Medical, Inc.?
The analyses noted slower momentum over the last 30 days compared to the last week, alongside a significant 91-day price decline. The price remains below key moving averages, and the company has experienced negative gross profit, net income, and operating cash flow in recent periods.
Is Picard Medical, Inc. bullish or bearish?
Recent AI analyses of Picard Medical, Inc. examined factors on both sides. Discussed upside: Recent analyses discussed a strong 7-day price change and positive short-term momentum, supported by extremely strong buying pressure indicated by the MFI. The company also reported year-over-year revenue growth of 39.1% and a significant decrease in total debt. Discussed risks: The analyses noted slower momentum over the last 30 days compared to the last week, alongside a significant 91-day price decline. The price remains below key moving averages, and the company has experienced negative gross profit, net income, and operating cash flow in recent periods. These are descriptive observations, not a recommendation.
What is the latest sentiment on Picard Medical, Inc.?
News reports presented a mixed picture, highlighting a contract manufacturing collaboration and broader economic indicators influencing market sentiment. A separate headline indicated that strong Purchasing Managers' Index readings complicated the Federal Reserve's path, causing a slight dip in futures.

Bundles used
gemini-low-v2

Run a fresh PMI.US analysis

Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.

Or sign in to read every PMI.US report already in the library



Most analyzed tickers

Market Scanner content is AI-generated for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Public pages show historical sample analyses, not current guidance.

© Market ScannerTermsRefund policyPrivacyCookiesContact